Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics.

Members of the Gram-positive bacterial genus Streptococcus are a diverse collection of species inhabiting many body sites and range from benign, nonpathogenic species to those causing life-threatening infections. The streptococci are also prolific producers of bacteriocins, which are ribosomally synthesized proteinaceous antibiotics that kill or inhibit species closely related to the producer bacterium. With the emergence of bacterial resistance to conventional antibiotics, there is an impetus to discover, and implement, new and preferably 'natural' antibiotics to treat or prevent bacterial infections, a niche that bacterial interference therapy mediated by bacteriocins could easily fill. This review focuses on describing the diversity of bacteriocins produced by streptococci and also puts forth a case for Streptococcus salivarius, a nonpathogenic and numerically predominant oral species, as an ideal candidate for development as the model probiotic for the oral cavity. S. salivarius is a safe species that not only produces broad-spectrum bacteriocins but harbors bacteriocin-encoding (and bacteriocin-inducing) transmissible DNA entities (megaplasmids).

[1]  W. Teughels,et al.  Aggregatibacter actinomycetemcomitans adhesion inhibited in a flow cell. , 2008, Oral microbiology and immunology.

[2]  John R. Tagg,et al.  Bacteriocin (Mutacin) Production by Streptococcus mutans Genome Sequence Reference Strain UA159: Elucidation of the Antimicrobial Repertoire by Genetic Dissection , 2005, Applied and Environmental Microbiology.

[3]  J. Tagg,et al.  Ubericin A, a Class IIa Bacteriocin Produced by Streptococcus uberis , 2007, Applied and Environmental Microbiology.

[4]  W. D. de Vos,et al.  Molecular Monitoring of Succession of Bacterial Communities in Human Neonates , 2002, Applied and Environmental Microbiology.

[5]  S. Wikner,et al.  Early Establishment of Streptococcus salivarius in the Mouths of Infants , 1970, Journal of dental research.

[6]  R. Facklam,et al.  What Happened to the Streptococci: Overview of Taxonomic and Nomenclature Changes , 2002, Clinical Microbiology Reviews.

[7]  C. J. Moore,et al.  Safety Assessment of the Oral Cavity Probiotic Streptococcus salivarius K12 , 2006, Applied and Environmental Microbiology.

[8]  M. Beukes,et al.  Self-Protection against Cell Wall Hydrolysis inStreptococcus milleri NMSCC 061 and Analysis of the Millericin B Operon , 2001, Applied and Environmental Microbiology.

[9]  J. Tagg,et al.  Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media? , 2003, Journal of medical microbiology.

[10]  W. Shi,et al.  Co‐ordinated bacteriocin production and competence development: a possible mechanism for taking up DNA from neighbouring species , 2005, Molecular microbiology.

[11]  F. Dewhirst,et al.  Diversity of Bacterial Populations on the Tongue Dorsa of Patients with Halitosis and Healthy Patients , 2003, Journal of Clinical Microbiology.

[12]  M. Jakobsen,et al.  Characterisation of the dominant microbiota of Sudanese fermented milk Rob , 2001 .

[13]  E. Breukink,et al.  Elucidation of the antimicrobial mechanism of mutacin 1140. , 2008, Biochemistry.

[14]  Rw Jack,et al.  Bacteriocins of grampositive bacteria , 1995 .

[15]  J. Tanzer,et al.  Inhibition of ecological emergence of mutans streptococci naturally transmitted between rats and consequent caries inhibition by Streptococcus salivarius TOVE-R infection , 1985, Infection and immunity.

[16]  D. Sgouras,et al.  In vitro and in vivo safety evaluation of the bacteriocin producer Streptococcus macedonicus ACA-DC 198. , 2009, International journal of food microbiology.

[17]  Leif Smith,et al.  Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics. , 2008, Current opinion in microbiology.

[18]  J. Tagg,et al.  Application of inhibitor typing in a study of the transmission and retention in the human mouth of the bacterium Streptococcus salivarius. , 1983, Archives of oral biology.

[19]  J. Tanzer,et al.  In vitro Studies of Growth and Competition between S. salivarius TOVE-R and Mutans Streptococci , 1986, Journal of dental research.

[20]  K Roos,et al.  Effect of recolonisation with “interfering” α streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial , 2001, BMJ : British Medical Journal.

[21]  P. Saris,et al.  Inhibition of Staphylococcus aureus by the commensal bacteria of human milk , 2003, Journal of applied microbiology.

[22]  J. Ferretti,et al.  Duplication of the lantibiotic structural gene in M-type 49 group A streptococcus strains producing streptococcin A-M49 , 1994, Applied and environmental microbiology.

[23]  S. Holm,et al.  Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. , 1993, International journal of pediatric otorhinolaryngology.

[24]  J. Tagg,et al.  The large antimicrobial proteins (bacteriocins) of streptococci , 2006 .

[25]  D. Mikulec MICROBIOLOGICAL STUDY OF FRESH WHITE CHEESE (A SERBIAN CRAFT VARIETY) , 2006 .

[26]  M. Obodai,et al.  Characterization of dominant microbiota of a Ghanaian fermented milk product, nyarmie, by culture‐ and nonculture‐based methods , 2006, Journal of applied microbiology.

[27]  Xiuzhu Dong,et al.  Streptococcus oligofermentans inhibits Streptococcus mutans through conversion of lactic acid into inhibitory H2O2: a possible counteroffensive strategy for interspecies competition , 2007, Molecular microbiology.

[28]  W. A. van der Donk,et al.  Biosynthesis and mode of action of lantibiotics. , 2005, Chemical reviews.

[29]  J. Tagg,et al.  A New Alkaline pH-Adjusted Medium Enhances Detection of β-Hemolytic Streptococci by Minimizing Bacterial Interference Due to Streptococcus salivarius , 2000, Journal of Clinical Microbiology.

[30]  S. Holm,et al.  Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study. , 1999, Acta oto-laryngologica.

[31]  W. Shi,et al.  Competition and Coexistence between Streptococcus mutans and Streptococcus sanguinis in the Dental Biofilm , 2005, Journal of bacteriology.

[32]  J. Xaus,et al.  The commensal microflora of human milk: new perspectives for food bacteriotherapy and probiotics , 2004 .

[33]  C. Ronson,et al.  Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3 , 1993, Applied and environmental microbiology.

[34]  J. Washington,et al.  Bacterial interference by Streptococcus salivarius. , 1975, American journal of clinical pathology.

[35]  J. Tagg,et al.  Salivaricin A2 and the Novel Lantibiotic Salivaricin B Are Encoded at Adjacent Loci on a 190-Kilobase Transmissible Megaplasmid in the Oral Probiotic Strain Streptococcus salivarius K12 , 2006, Applied and Environmental Microbiology.

[36]  J. Tagg,et al.  Identification of nlmTE, the Locus Encoding the ABC Transport System Required for Export of Nonlantibiotic Mutacins in Streptococcus mutans , 2005, Journal of bacteriology.

[37]  C. Callon,et al.  Diversity of lactic acid bacteria isolated from AOC Salers cheese , 2004, Journal of Dairy Research.

[38]  J. Tagg,et al.  The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics. , 2005, Oral diseases.

[39]  H. C. Mantovani,et al.  Bovicin HC5, a Lantibiotic Produced by Streptococcus bovis HC5, Catalyzes the Efflux of Intracellular Potassium but Not ATP , 2008, Antimicrobial Agents and Chemotherapy.

[40]  H. Derendorf,et al.  Pharmacodynamic activity of the lantibiotic MU1140. , 2009, International journal of antimicrobial agents.

[41]  J. Tagg,et al.  Copyright � 1995, American Society for Microbiology Bacteriocins of Gram-Positive Bacteria , 1995 .

[42]  F. Qi,et al.  Purification of Mutacin III from Group IIIStreptococcus mutans UA787 and Genetic Analyses of Mutacin III Biosynthesis Genes , 1999, Applied and Environmental Microbiology.

[43]  Marcus B. Jones,et al.  Peptide alarmone signalling triggers an auto‐active bacteriocin necessary for genetic competence , 2009, Molecular microbiology.

[44]  J. Tagg Streptococcal Bacteriocin-Like Inhibitory Substances: Some Personal Insights into the Bacteriocin-Like Activities Produced by Streptococci Good and Bad , 2009, Probiotics and antimicrobial proteins.

[45]  E. Zoetendal,et al.  Cultivation-independent assessment of the bacterial diversity of breast milk among healthy women. , 2007, Research in microbiology.

[46]  M. Dufour,et al.  Targeting of streptococci by zoocin A. , 2007, FEMS microbiology letters.

[47]  C. J. Moore,et al.  Production of the Lantibiotic Salivaricin A and Its Variants by Oral Streptococci and Use of a Specific Induction Assay To Detect Their Presence in Human Saliva , 2006, Applied and Environmental Microbiology.

[48]  MacFarlane Tw The oral ecology of patients with severe Sjogren's syndrome. , 1984 .

[49]  A. Haffajee,et al.  Guiding Periodontal Pocket Recolonization: a Proof of Concept , 2007, Journal of dental research.

[50]  Armando Albert,et al.  Peptide AS-48: prototype of a new class of cyclic bacteriocins. , 2004, Current protein & peptide science.

[51]  M. Lavoie,et al.  In vivo activity of mutacin B-Ny266. , 2005, The Journal of antimicrobial chemotherapy.

[52]  J. Hillman,et al.  Development and validation of a LC-MS quantification method for the lantibiotic MU1140 in rat plasma. , 2009, Journal of pharmaceutical and biomedical analysis.

[53]  A. Driessen,et al.  Mutacin II, a bactericidal antibiotic from Streptococcus mutans , 1995, Antimicrobial agents and chemotherapy.

[54]  J. Tagg,et al.  Molecular and Genetic Characterization of a Novel Nisin Variant Produced by Streptococcus uberis , 2006, Applied and Environmental Microbiology.

[55]  I. Brook,et al.  Bacterial interference in the nasopharynx and nasal cavity of sinusitis prone and non-sinusitis prone children. , 1999, Acta oto-laryngologica.

[56]  A. Taketo,et al.  New gene cluster for lantibiotic streptin possibly involved in streptolysin S formation. , 2001, Journal of biochemistry.

[57]  C. J. Moore,et al.  A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters , 2006, Journal of applied microbiology.

[58]  M. Moeschberger,et al.  Changes in Periodontal Health Status Are Associated with Bacterial Community Shifts as Assessed by Quantitative 16S Cloning and Sequencing , 2006, Journal of Clinical Microbiology.

[59]  K. Hisamatsu,et al.  Interaction between Oral Alpha-Streptococci and Group a Streptococci in Patients with Tonsillitis , 1997, The Annals of otology, rhinology, and laryngology.

[60]  W Teughels,et al.  Reduction of periodontal pathogens adhesion by antagonistic strains. , 2007, Oral microbiology and immunology.

[61]  J. Tagg,et al.  Purification and Characterization of Streptin, a Type A1 Lantibiotic Produced by Streptococcus pyogenes , 2003, Applied and Environmental Microbiology.

[62]  C. Sanders,et al.  Bacterial interference: effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci , 1976, Infection and immunity.

[63]  G. Reid,et al.  Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius , 2006, Antonie van Leeuwenhoek.

[64]  S. Holm,et al.  Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study. , 1993, Scandinavian journal of infectious diseases.

[65]  J. Tagg,et al.  Uberolysin: a novel cyclic bacteriocin produced by Streptococcus uberis. , 2007, Microbiology.

[66]  J. S. van der Hoeven,et al.  Sulfate-reducing bacteria in the periodontal pocket. , 1995, Oral microbiology and immunology.

[67]  C. Crowe,et al.  Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A Streptococcus. , 1973, The Journal of infectious diseases.

[68]  M. Neely,et al.  SalY of the Streptococcus pyogenes Lantibiotic Locus Is Required for Full Virulence and Intracellular Survival in Macrophages , 2007, Infection and Immunity.

[69]  C. Dalidowitz Fortified breast milk safety. , 2005, Journal of the American Dietetic Association.

[70]  J. Tagg,et al.  Diverse Activity Spectra of Bacteriocin–Like Inhibitory Substances Having Activity against Mutans Streptococci , 2000, Caries Research.

[71]  C. J. Moore,et al.  The effect of ingestion of milk supplemented with salivaricin A-producing Streptococcus salivarius on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue. , 2007, FEMS microbiology ecology.

[72]  Ping Chen,et al.  The Group I Strain of Streptococcus mutans, UA140, Produces Both the Lantibiotic Mutacin I and a Nonlantibiotic Bacteriocin, Mutacin IV , 2001, Applied and Environmental Microbiology.

[73]  P. Vandamme,et al.  Diversity of lactic acid bacteria in two Flemish artisan raw milk Gouda-type cheeses. , 2008, Food microbiology.

[74]  J. S. van der Hoeven,et al.  Streptococci and actinomyces inhibit regrowth of Streptococcus mutans on gnotobiotic rat molar teeth after chlorhexidine varnish treatment. , 1995, Caries research.

[75]  R. Gibbons,et al.  Suppression of Candida albicans by Human Oral Streptococci in Gnotobiotic Mice , 1973, Infection and immunity.

[76]  J. Tagg,et al.  Intra- and Interspecies Signaling betweenStreptococcus salivarius and Streptococcus pyogenes Mediated by SalA and SalA1 Lantibiotic Peptides , 2001, Journal of bacteriology.

[77]  D. Cvitkovitch,et al.  Modification of an effector strain for replacement therapy of dental caries to enable clinical safety trials , 2007, Journal of applied microbiology.

[78]  S. Holm,et al.  Inhibition of OM pathogens by alpha-hemolytic streptococci from healthy children, children with SOM and children with rAOM. , 2000, International journal of pediatric otorhinolaryngology.

[79]  F. Qi,et al.  Purification and Biochemical Characterization of Mutacin I from the Group I Strain of Streptococcus mutans, CH43, and Genetic Analysis of Mutacin I Biosynthesis Genes , 2000, Applied and Environmental Microbiology.

[80]  Xin Zhao,et al.  Bovicin HJ50, a novel lantibiotic produced by Streptococcus bovis HJ50. , 2004, Microbiology.

[81]  Y. Izumi,et al.  Significant association between score of periodontal disease and coronary artery disease , 2009, Heart and Vessels.

[82]  M. Kilian,et al.  Ecology of viridans streptococci in the oral cavity and pharynx. , 1991, Oral microbiology and immunology.

[83]  J. Tagg,et al.  Isolation and partial characterization of the Streptococcus mutans type AII lantibiotic mutacin K8. , 2007, Microbiology.

[84]  J. Tagg,et al.  Sequence analysis of pDN571, a plasmid encoding novel bacteriocin production in M-type 57 Streptococcus pyogenes. , 2004, Plasmid.

[85]  V. Fantinato,et al.  Production of bacteriocin-like inhibitory substances (BLIS) by Streptococcus salivarius strains isolated from the tongue and throat of children with and without sore throat , 1999 .

[86]  H. Kuramitsu,et al.  Genetic Analysis of a Unique Bacteriocin, Smb, Produced by Streptococcus mutans GS5 , 2005, Antimicrobial Agents and Chemotherapy.

[87]  T. Yamada,et al.  [Incidence of alpha-streptococcus having inhibitory activity against beta-streptococcus in patients with tonsillitis]. , 1992, Nihon Jibiinkoka Gakkai kaiho.

[88]  C. Jones,et al.  The Streptococcal Bacteriocin-like Inhibitory Substance, Zoocin A, Reduces the Proportion of Streptococcus mutans in an Artificial Plaque , 1994 .

[89]  J. Tagg,et al.  Mode of action of dysgalacticin: a large heat-labile bacteriocin. , 2009, The Journal of antimicrobial chemotherapy.

[90]  J. Tagg,et al.  Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin. , 2005, FEMS microbiology letters.

[91]  J. Tanzer,et al.  Competitive displacement of mutans streptococci and inhibition of tooth decay by Streptococcus salivarius TOVE-R , 1985, Infection and immunity.

[92]  J. Oh,et al.  Effect of Weissella cibaria Isolates on the Formation of Streptococcus mutans Biofilm , 2006, Caries Research.

[93]  Jae-Hong Park,et al.  Molecular analysis of colonized bacteria in a human newborn infant gut. , 2005, Journal of microbiology.

[94]  E. Sanders,et al.  Bacterial interference. I. Its occurrence among the respiratory tract flora and characterization of inhibition of group A streptococci by viridans streptococci. , 1969, The Journal of infectious diseases.

[95]  G. Tompkins,et al.  Identification and characterization of the loci encoding the competence-associated alternative sigma factor of Streptococcus gordonii. , 2006, FEMS microbiology letters.

[96]  R. P. Ross,et al.  Lantibiotics: structure, biosynthesis and mode of action. , 2001, FEMS microbiology reviews.

[97]  J. Tagg,et al.  Dysgalacticin: a novel, plasmid-encoded antimicrobial protein (bacteriocin) produced by Streptococcus dysgalactiae subsp. equisimilis. , 2006, Microbiology.

[98]  M. Neely,et al.  First Streptococcus pyogenes Signature-Tagged Mutagenesis Screen Identifies Novel Virulence Determinants , 2009, Infection and Immunity.

[99]  R. Anastasiou,et al.  Characterization of the gene cluster involved in the biosynthesis of macedocin, the lantibiotic produced by Streptococcus macedonicus. , 2007, FEMS microbiology letters.

[100]  K. Venugopal,et al.  Epidemiology of acute rheumatic fever in New Zealand 1996–2005 , 2008, Journal of paediatrics and child health.

[101]  J. Tagg,et al.  "Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. , 1979, Journal of medical microbiology.

[102]  G. Tompkins,et al.  Competence-Dependent Bacteriocin Production by Streptococcus gordonii DL1 (Challis) , 2006, Journal of bacteriology.

[103]  D. Cvitkovitch,et al.  Genetic and Biochemical Analysis of Mutacin 1140, a Lantibiotic from Streptococcus mutans , 1998, Infection and Immunity.

[104]  J. V. Van Beeumen,et al.  Macedocin, a Food-Grade Lantibiotic Produced by Streptococcus macedonicus ACA-DC 198 , 2002, Applied and Environmental Microbiology.